IQVIA is proud to announce that the IQVIA Interactive Response Technology (IRT) Supply Automation Value Engine (SAVE) has won a Silver Stevie^® Award winner in the Health & Pharmaceuticals – Product category at the 2026 American Business Awards^®.

This recognition underscores IQVIA’s continued commitment to advancing innovation that helps life sciences organizations run smarter, more efficient clinical trials—particularly in one of the most complex and high impact areas of trial execution: clinical supply planning and management.

Why IRT SAVE Stood Out

The American Business Awards recognize organizations and products that demonstrate excellence, innovation, and measurable impact. Winning a Silver Stevie places IRT SAVE among a highly competitive group of health and pharmaceutical solutions evaluated by an independent panel of judges.

Judges recognized the technical depth and sophistication of IRT SAVE, highlighting its advanced approach to automating and optimizing clinical supply decisions in an increasingly complex trial environment.

Beyond the technical recognition, the award reflects the people and collaboration behind IRT SAVE.

“We’re incredibly proud of the team and the work that went into building IRT SAVE. This recognition is a direct reflection of the collaboration, innovation, and commitment across IQVIA to solving real world clinical supply challenges,” says Stefan Dürr, Senior Director Digital Products & Solutions, Patient Delivery.

Addressing One of Clinical Trials’ Biggest Challenges

Clinical supply misalignment can lead to costly drug waste, patient delays, site frustration, and operational risk. IRT SAVE was designed specifically to address these challenges by bringing greater intelligence, automation, and predictability to IRT driven supply planning.

As part of IQVIA’s IRT portfolio, SAVE enables sponsors to more effectively:

• Anticipate supply risks earlier
• Optimize inventory levels across depots and sites
• Reduce overproduction and waste
• Support smoother patient enrollment without supply disruptions

By combining automation with advanced modeling, IRT SAVE helps clinical teams move beyond reactive supply management toward a more proactive, data driven approach—an area increasingly critical as trials grow more global, adaptive, and complex.

Recognition That Reflects Real World Impact

While the IRT SAVE submission highlighted technical complexity, the Silver Stevie Award affirms its real operational value. The recognition underscores the importance of investing in innovative infrastructure that quietly but critically enables trial success—and adds to IQVIA’s growing track record of delivering solutions that help sponsors and CROs run faster, higher quality trials with lower operational burden.

Learn more about IRT SAVE and its impact on clinical trial supply management.